Related Experiment Video
Updated: Oct 20, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Activity of glycogen synthase kinase-3beta is down-regulated during transient differentiation of human colon cancer
Z Tuhackova1, E Sloncova, J Hlavacek
1Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, 166 37 Praha 6, Czech Republic.
Abstract:
The increased phosphorylation and activity of protein kinase B (PKB/Akt) was found early upon butyrate treatment of HT-29 cells with a potent differentiating agent, sodium butyrate. It was accompanied by the increased phosphorylation of glycogen synthase kinase-3 (GSK-3) and the inhibition of the activity of GSK-3beta to catalyze phosphorylation of its substrate, translation initiation factor eIF2B. Phosphorylation of PKB and GSK-3 in HT-29 cells was reduced by wortmannin, the inhibitor of phosphatidylinositol-3' kinase (PI3'-kinase), which is upstream activator of PKB and GSK-3 in the intracellular signalling. Modulation of the activity and phosphorylation of these protein kinases during transient in vitro differentiation of HT-29 cells indicates that control of the PI3'-kinase/PKB-dependent signalling pathway may be implicated very early in the changes of malignant phenotype of HT-29 cells.
Insights
Sodium butyrate treatment increases protein kinase B (PKB/Akt) and glycogen synthase kinase-3 (GSK-3) phosphorylation in HT-29 cells. This suggests the phosphatidylinositol-3
Area of Science:
- Cellular biology
- Molecular signaling
- Cancer research
Background:
- Sodium butyrate is a potent differentiating agent used in cancer research.
- HT-29 cells are a human colorectal adenocarcinoma cell line often used to study differentiation.
- Protein kinase B (PKB/Akt) and glycogen synthase kinase-3 (GSK-3) are key intracellular signaling molecules.
Purpose of the Study:
- To investigate the early effects of sodium butyrate on intracellular signaling pathways in HT-29 cells.
- To determine the role of the phosphatidylinositol-3' kinase (PI3'-kinase)/PKB signaling pathway in butyrate-induced differentiation.
Main Methods:
- Treatment of HT-29 cells with sodium butyrate.
- Assessment of protein phosphorylation and kinase activity using biochemical assays.
- Inhibition of phosphatidylinositol-3' kinase (PI3'-kinase) with wortmannin.
Main Results:
- Early increase in protein kinase B (PKB/Akt) and glycogen synthase kinase-3 (GSK-3) phosphorylation upon butyrate treatment.
- Inhibition of GSK-3beta activity towards its substrate, translation initiation factor eIF2B.
- Wortmannin reduced PKB and GSK-3 phosphorylation, indicating PI3'-kinase pathway involvement.
Conclusions:
- The PI3'-kinase/PKB-dependent signaling pathway is modulated early during transient in vitro differentiation of HT-29 cells.
- Control of this pathway may be implicated in the early changes of the malignant phenotype of HT-29 cells.
- These findings highlight a potential therapeutic target for colorectal cancer.
Related Concept Videos
TGF - β Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cell Specific Gene Expression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

